Medigen Vaccine Biologics

Samsung Biologics will be entering the drug substance segment of the COVID-19 vaccine contract manufacturing business. According to industry sources...

SK Bioscience Co. has secured additional funding for phase III clinical trial of GBP510, its COVID-19 vaccine candidate jointly developed with the I...

Samsung Biologics Co. will be manufacturing the US company Moderna’s COVID-19 vaccine (mRNA-1273) from the second half of this year in Korea. ...

South Korea’s Samsung Biologics Co. is in talks with Pfizer Inc.to produce the US drugmaker’s COVID-19 vaccine under a contract manufact...

South Korea’s biosimilar and pharmaceutical companies are looking at a growing chance of emerging as a global hub for manufacturing vaccines f...

Genexine Inc., one of the five South Korean pharmaceutical companies whose COVID-19 vaccine candidates have entered clinical trials, will export its...

South Korea’s SK Bioscience Co. is suspending production of SKYCellflu, an influenza vaccine, to focus on manufacturing COVID-19 vaccines inst...

South Korea’s pharmaceutical company Green Cross Corporation (GC) is holding a series of close meetings on contract manufacturing of Russia&rs...

South Korea’s SK Bioscience Co. is looking to post 1 trillion won ($900 million) in annual revenue from its vaccine business as the biopharmac...

South Korea-based Celltrion Inc. has alluded to the possibility of developing a COVID-19 vaccine on the grounds that securing a vaccine is essential...

Samsung Biologics Co. delivered forecast-beating earnings this week, with its sales topping 1 trillion won ($905 million) for the first time in its ...

South Korea’s treasury yields are heading higher as advances in vaccine development and concerns over increased government bond sales prompt f...

SK Holdings is in the early stages of negotiations to acquire France’s biologic contract manufacturing organization (CMO) Yposkesi, in a move ...

It's a busy day at the Korea Superfreeze warehouse in South Korea's Gyeonggi province, with trucks entering and exiting the spacious 92,500-square...

South Korea's SK Holdings Co. may hit the jackpot with the development of a COVID-19 vaccine on the horizon.Once a coronavirus vaccine is available, t...

Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO) in terms of capacity, posted an operating profit of 200.2 b...

SK Bioscience Co. Ltd. has secured a contract manufacturing organization (CMO) order for a new coronavirus vaccine candidate under development by the ...

Samsung Biologics Co. Ltd., the world’s largest contract manufacturing organization (CMO) in terms of capacity, will invest 1.74 trillion won ($...